报告名称：Cipla(CIPLA IN)Buy：One offs impact 4Q；US can lead recovery
报告类型：海外市场
报告日期：2016-05-25
研究机构：汇丰银行
页数：11
简介：4QFY16 reported PAT includes multiple one-offs, excludingwhich base EBITDA margin declined 100bps qoq to 13.6%
US sales partly include InvaGen; full impact and new launchesshould augur well for the US in FY17
Medium-term guidance moderate on continuing investments;maintain Buy rating with revised TP of INR570 (from INR702)
下载地址：Cipla(CIPLA IN)Buy：One offs impact 4Q；US can lead recovery
